Virtual Medicinal Product (VMP) - Salicylamide 5% / Benzocaine 2% gel
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Salicylamide 5% / Benzocaine 2% gel | Start Date 22-10-2002 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Cutaneous
- Form
- Cutaneous gel
- Ontology Form/Route
- gel.cutaneous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- Other
Codes
- BNF Codes
-
- BNF code 10030200
| Code | Start Date | End Date |
|---|---|---|
| 41744711000001100 | 02-05-2023 | |
| 347331004 | 22-10-2002 | 01-05-2023 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Benzocaine | Based on Ingredient Substance | 20 mg | 1 gram | |
| Salicylamide | Based on Ingredient Substance | 50 mg | 1 gram |
Name
Salicylamide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
1
Name
Benzocaine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20
Strength and UOM (Dmr)
1
Parent Products
-
VTMSalicylamide + Benzocaine
-
VMP(Current) Salicylamide 5% / Benzocaine 2% gel
-
AMP
No AMPs
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 50 gram |